John Graham, Group CEO of Zuellig Pharma, talks about election risks, US-China tensions, and how tariffs and protectionism could affect the pharmaceutical industry.
John Graham, Group CEO of Zuellig Pharma, talks about election risks, US-China tensions, and how tariffs and protectionism could affect the pharmaceutical industry.